DEferiprone Evaluation in Paediatrics

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Publicaciones

Integration of PKPD relationships into benefit–risk analysis

Autores: Francesco Bellanti; Rob C. van Wijk; Meindert Danhof; Oscar Della Pasqua; Oscar Della Pasqua
Publicado en: WileyBritish Journal of Clinical Pharmacology 2015
Identificador permanente: Digital Object Identifier:10.1111/bcp.12674; PubMed ID:25940398; PubMed Central ID:PMC4631171; Microsoft Academic Graph Identifier:1498337068; Handle:1887/3197908

Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassaemia major: the DEEP-3 multi-centre observational safety study

Autores: Botzenhardt, S.; Felisi, M.; Bonifazi, D.; Del Vecchio, G.C.; Putti, M.C.; Kattamis, A.; Ceci, A.; Wong, I.C.K.; Neubert, A.; DEEP consortium (collaborative group)

Sampling Optimization in Pharmacokinetic Bridging Studies: Example of the Use of Deferiprone in Children With β‐Thalassemia

Autores: Meindert Danhof; Francesco Bellanti; Vincenzo Luca Di Iorio; Oscar Della Pasqua; Oscar Della Pasqua
Publicado en: WileyJournal of Clinical Pharmacology 2016
Identificador permanente: Digital Object Identifier:10.1002/jcph.708; PubMed ID:26785826; Microsoft Academic Graph Identifier:2260299951

Ethical and Procedural Issues For Applying Researcher-Driven Multi-National Paediatric Clinical Trials in and Outside The European Union: The Challenging Experience of The DEEP Project

Autores: Viviana Giannuzzi; Mariagrazia Felisi; Donato Bonifazi; Hugo Devlieger; George Papanikolaou; Lamis Ragab; Slaheddine Fattoum; Bianca Tempesta; Giorgio Reggiardo; Adriana Ceci
Publicado en: Research Square Platform LLCBMC Medical Ethics, Vol 22, Iss 1, Pp 1-11 (2021) 2021
Identificador permanente: Digital Object Identifier:10.21203/rs.3.rs-200496/v1; Digital Object Identifier:10.1186/s12910-021-00618-2; Digital Object Identifier:10.60692/df18a-0gf94; Digital Object Identifier:10.60692/h112x-kjs28; PubMed ID:33926431; PubMed Central ID:PMC8086274; Microsoft Academic Graph Identifier:3133161322

Evaluation of the effectiveness and safety of deferiprone compared to deferasirox in pediatric patients with transfusion-dependent hemoglobinopathies (DEEP-2): a multicenter, randomized, open label, non-inferiority, phase-III trial

Autores: Maggio, A; Kattamis, A; Felisi, M; Reggiardo, G; El-Beshlawy, A; Bejaoui, M; Sherief, L; Christou, S; Cosmi, C; Della Pasqua, O; Del Vecchio, DC; Filosa, A; Cuccia, L; Hassab, H; Kreka, M; Origa, R; Putti, MC; Spino, M; Telfer, P; Tempesta, B; Vitrano, A; Tsang, YC; Zaka, A; Tricta, F; Bonifazi, D; Ceci, A

Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years

Autores: Bellanti, F; Del Vecchio, GC; Putti, MC; Maggio, A; Filosa, A; Cosmi, C; Mangiarini, L; Spino, M; Connelly, J; Ceci, A; Della Pasqua, O
Publicado en: WileyBritish Journal of Clinical Pharmacology 2016
Identificador permanente: Digital Object Identifier:10.1111/bcp.13134; PubMed ID:27641003; PubMed Central ID:PMC5306498; Microsoft Academic Graph Identifier:2522933058

Safety profiles of iron chelators in young patients with haemoglobinopathies

Autores: Antje Neubert; Sebastian Botzenhardt; Niya Li; Niya Li; Chor-Wing Sing; Ian C. K. Wong; Ian C. K. Wong; Esther W. Chan
Publicado en: WileyCrossref 2017
Identificador permanente: Digital Object Identifier:10.1111/ejh.12833; PubMed ID:27893170; Microsoft Academic Graph Identifier:2557836944; Handle:10722/241778

Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen

Autores: Viviana Giannuzzi; Rosa Conte; Annalisa Landi; Serena Antonella Ottomano; Donato Bonifazi; Paola Baiardi; Fedele Bonifazi; Adriana Ceci
Publicado en: Springer Science and Business Media LLCOrphanet J Rare Dis 2017
Identificador permanente: Digital Object Identifier:10.1186/s13023-017-0617-1; PubMed ID:28372595; PubMed Central ID:PMC5376695; Microsoft Academic Graph Identifier:2605334227

Safety Profile of Oral Iron Chelator Deferiprone in Chinese Children with Transfusion-Dependent Thalassaemia

Autores: Wong, LY; Sing, CW; Ceci, A; Chan, GCF; Felisi, M; Neubert, A; Botzenhardt, S; Rascher, W; Wong, IC
Publicado en: Bentham Science Publishers Ltd.Current Drug Safety 2016
Identificador permanente: Digital Object Identifier:10.2174/1574886310666150930113957; PubMed ID:26419768; Microsoft Academic Graph Identifier:2299144032; Handle:10722/234086

Clinical Trial Application in Europe: What Will Change with the New Regulation?

Autores: Viviana Giannuzzi; Annagrazia Altavilla; Lucia Ruggieri; Adriana Ceci
Publicado en: Springer Science and Business Media LLCScience and Engineering Ethics 2015
Identificador permanente: Digital Object Identifier:10.1007/s11948-015-9662-0; PubMed ID:26037896; Microsoft Academic Graph Identifier:657111361

Showing 1-10 out of 11

Publicaciones

Compartir esta página

Descargar